High Quality Content by WIKIPEDIA articles! Tocilizumab (INN, or atlizumab, developed by Hoffmann–La Roche and Chugai and sold under the trade names Actemra and RoActemra) is an immunosuppressive drug, mainly for the treatment of rheumatoid arthritis (RA)

В наличии:
	Sprinter - 1238 руб.	Перейти		Лучшая цена
	Books.Ru - 1385 руб.	Перейти

Рейтинг книги: 4 из 5, 9 голос(-ов).